Neuroscience: from molecular mechanisms to disease

BIO-480

This file is part of the content downloaded from Neuroscience: from molecular mechanisms to disease.


Week 1 (9 & 13/09) - Introduction/Techniques/Brain Anatomy I


Week 2 (20/09) - Brain Anatomy II


Week 3 (23 & 27/09) - Neurodevelopment and Neurogenesis


Week 4 (30/09 & 04/10) - Glia and Motor neurons and disease I


Week 5 (07/10 & 11/10) Motor neurons and disease II & III


Week 6 (14/10 & 18/10) - Basal ganglia and Parkinson's disease I and II

Basal ganglia

Parkinson's disease: general facts, symptoms, genetics

Symptomatic treatments: dopamine replacement, deep brain stimulation

Alpha-synuclein pathology: characteristics, link to symptoms, propagation

Organelle quality control



Week 7 (28/10 & 01/11): Alzheimer's disease I and II


Week 8 (04/11 & 08/11): Role of protein misfolded in neurodegenerative diseases

I. Global health and economic burden of NDDs (4/11)

II. Main features of the neurodegenerative diseases (NDDs) (4/11)

III. NDDs: the role of misfolded proteins (4/11)

IV. The prion-like hypothesis (4/11)

V. Spreading of pathology in the brain: the gut-brain axis hypothesis (8/11)

VI. Gain-of-Function vs. Loss-of-Function hypotheses (8/11)



Week 9 (11/11 & 15/11): Biomarkers, therapeutics in PD and aging

11/11: Biomarkers and emerging therapeutics in PD

Overview of the latest advances in drug design and therapies in PD: from bench to bedside


Parkinson's disease
Lecture III:
Alpha-synuclein in CNS physiology and pathology
Autophagy and mechanisms of organelle quality control


Week 10 (18/11 & 22/11): NeuroTherapeutics and Gene Therapy I & II

Gene therapy for neurological diseases and sensory organs

General principles, ex vivo and in vivo gene therapy

Viral vector technologies: AAV vectors, capsid evolution

Application 1: motor system

Application 2: sensory organs (blindness, deafness)


Week 11 (25/11 & 29/11): Neuroepigenetics


Week 12 (02/12 & 06/12): Personalised medicine and translational approaches against neurodegeneration I- visit of PD patients

02/12: Gene therapy for neurological diseases and sensory organs

General principles, ex vivo and in vivo gene therapy

Viral vector technologies: AAV vectors, capsid evolution

Application 1: motor system

Application 2: sensory organs (blindness, deafness)

06/12: Visit PD patients


Week 13 (09/12 & 13/12): Debate on the drivers of NDD pathogenesis and Clinical trial

09/12: Debate on treatments targeting Amyloid beta

13/12: Clinical trial in PD


Week 14 (16/12 & 20/12): Mock exam and mock exam correction

The mock exam will be discussed via Zoom on December 20 2024, 10:15am.

The zoom link is: epfl.zoom.us/my/johannesgraeff

The presence time of the teachers has changed - it is now: 

10.15-10.45: Bernard Schneider (BS)

10.45-11.15: Johannes Gräff (JG)

11.15-11.45: Anne-Laure Mahul-Mellier (ALMM)